InvestSMART

The article you are trying to access does not exist, however, here are some articles you may be interested in.

AVITA Medical, Inc. (ASX: AVH) - Share Price

Current share price for AVH : $1.085 0.02 (1.81%)+

AVITA Medical, Inc. is a therapeutic acute wound care company delivering transformative solutions. Technologies are designed to optimize wound healing, effectively accelerating the time to patient recovery. At the forefront of platform is the RECELL System, approved by the U.S. Food and Drug Administration for the treatment of thermal burn and trauma wounds.

AVH General Information +

ASX Code AVH
Website http://avitamedical.com
Industry/Sector Biotechnology
Market Cap ($M) 166
AVH Share Price $1.085
Day High $1.105
Day Low $1.080
Last Close $1.105
AVH Share Price Movement $0.02 ( 1.81% )
Prices as at 15:35, 17 Jun 2026
+Security prices are delayed by at least 20 minutes and are indicative only.

AVITA Medical, Inc. (AVH) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield

See all dividends from AVITA Medical, Inc. (AVH) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

AVITA Medical, Inc. (AVH) price-sensitive announcements

AVH - Financial Results for Quarter Ending 31 March 2026
AVITA Medical, Inc. reported financial results for the quarter ending March 31, 2026, with
AVITA Medical, Inc. (AVH)
15 May 2026 | 8:23 AM
AVH - AVITA Medical Q1 2026 Earnings Presentation
AVITA Medical's Q1 2026 earnings presentation highlights strong performance improvements c
AVITA Medical, Inc. (AVH)
15 May 2026 | 8:23 AM
AVH - AVITA Medical Reports First Quarter 2026 Financial Results
AVITA Medical, Inc. reported its financial results for the first quarter of 2026, highligh
AVITA Medical, Inc. (AVH)
15 May 2026 | 8:23 AM
AVH - AVITA Medical Names Cary Vance as Chief Executive Officer
AVITA Medical, Inc., a leading company in therapeutic acute wound care, announced the appo
AVITA Medical, Inc. (AVH)
1 May 2026 | 8:17 AM

AVITA Medical, Inc. (AVH) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
AVITA Medical, Inc. (AVH)
CHESS DEPOSITARY INTERESTS 5:1
 Health Care $167 Financial Report on Form 8-K Dated 5 June 2026 11 Jun 2026 10:26AM $1.145 $1.085 fallen by 5.24%
AVITA Medical, Inc. (AVH)
CHESS DEPOSITARY INTERESTS 5:1
 Health Care $167 Change of Director's Interest Notice -SC JCC RM JSR MT CV JW 11 Jun 2026 10:24AM $1.145 $1.085 fallen by 5.24%
AVITA Medical, Inc. (AVH)
CHESS DEPOSITARY INTERESTS 5:1
 Health Care $167 Notification regarding unquoted securities - AVH 11 Jun 2026 10:23AM $1.145 $1.085 fallen by 5.24%
AVITA Medical, Inc. (AVH)
CHESS DEPOSITARY INTERESTS 5:1
 Health Care $167 Notification regarding unquoted securities - AVH 11 Jun 2026 10:04AM $1.135 $1.085 fallen by 4.41%
AVITA Medical, Inc. (AVH)
CHESS DEPOSITARY INTERESTS 5:1
 Health Care $167 Statement of CDIs on issue - AVH 4 Jun 2026 10:28AM $1.155 $1.085 fallen by 6.06%
AVITA Medical, Inc. (AVH)
CHESS DEPOSITARY INTERESTS 5:1
 Health Care $167 2026 ASM Board Chair Script 4 Jun 2026 9:48AM $1.130 $1.085 fallen by 3.98%

AVH Financial Summary

Year to Dec NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2025F -$41.15 -$31.40 0.00% -8.98 0.00 0.00% 0.0%
2024F -$86.81 -$66.23 0.00% -4.26 0.00 0.00% 0.0%
2023A -$60.93 -$48.11 0.00% -8.36 0.00 0.00% 0.0%

AVH Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2023 A 2024 F 2025 F 2023 A 2024 F 2025 F 2023 A 2024 F 2025 F
AVITA Medical, Inc. (AVH) $93M -0.3220 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
CSL Limited (CSL) $50,540M 0.1108 -0.1347 0.0438 11.3160 13.0770 12.5286 4.22% 3.40% 3.53%
Clinuvel Pharmaceuticals Limited (CUV) $466M 0.0287 0.0233 0.0942 12.8830 12.5902 11.5064 0.54% 0.78% 1.26%
Mesoblast Limited (MSB) $2,531M 0.0301 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
Telix Pharmaceuticals Limited (TLX) $4,680M -1.3893 0.0000 -0.1295 0.0000 258.7242 297.1983 0.00% 0.00% 0.00%

AVH Market Comparison

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.00 0.00 -1.36 0.00
Market 0.30 13.20 1.18 0.68
Sector 0.40 27.30 2.51 2.19

AVH Directors

Name Position Start Date
Mr Cary Vance Chief Executive Officer, President 1 Apr 2023
Ms Jan Stern Reed Non-Executive Chairman 1 Jul 2021
Professor Suzanne Crowe Non-Executive Director 13 Jan 2016
Mr Jeremy Curnock-Cook Non-Executive Director 19 Oct 2012
Mr Robert McNamara Non-Executive Director 1 Apr 2023
Dr Michael Eric Tarnoff Non-Executive Director 7 Aug 2025
Mr Joseph(Joe) Fralin Woody Non-Executive Director 1 Jan 2026

AVITA Medical, Inc. (AVH) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
4 Jun 2026 WOODY , Joseph(Joe) Buy Direct Shares 25,200 $4.113 $103,649.000
3 Jun 2026 WOODY , Joseph(Joe) Buy Direct Shares 20,000 $4.247 $84,936.500
30 May 2026 VANCE, Cary Buy Direct Shares 5,000 $3.052 $15,257.500

See all changes in directors' interest & trades for AVITA Medical, Inc. (AVH) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

AVH Management

Name Position
David O'Toole Chief Financial Officer (Principal Financial and Accounting Officer)
Nicole Linda Kelsey Chief Legal and Compliance Officer,Company Secretary
Mark Andrew Licciardo Company Secretary

AVH Calendar of Events

Date Event
12 February 2027 Report (Annual)
12 February 2027 Report (Prelim)
07 August 2026 Report (Interim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.